BioWorld Asia

Nov. 13, 2002

Partnerships Still Key Strategy For Biotech, Pharma Companies

STUTTGART, Germany - The eighth BIO-Europe 2002 International Partnering Conference drew approximately 1,200 representatives from all sectors of the biotechnology industry to Stuttgart to concentrate on partnering and making deals. (BioWorld International) Read More

New EuropaBio Leader Wants Backing For Biotech Research

Concealment Strategy Of Cancer Virus Could Point To Therapies

GW Releases Positive Phase III Results With Cannabis Drug

Meridian, Biotrin Call Off Merger Talks, Decline To Provide Details

EU Launches Its New Research Program At 3-Day Conference

Biotech Investing Strategies Shift To Deal With Bear Market

Genome Campus At Science Park Finally Granted OK To Go Ahead

Genfit Enters Cardiovascular Deal With Japanese Company

Serono Acquires 92 Percent of Genset, Collaborates with IVAX

Other News to Note

Today's news in brief

BioWorld

BioWorld briefs for March 9, 2026.

Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

Cas and effect: Merck’s phase III ripples HIF-2α space

BioWorld

Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...

Tanycytes in green capturing tau protein in red.

Brain’s hidden tau-clearing pathway uncovered

BioWorld Science

Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 10, 2026

MSD synthesizes α-synuclein PET agents

BioWorld Science

Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...